Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -99,560 | 41,955 | 15,909 | 41,980 | 145,523 |
| Depreciation Amortization | 82,007 | 79,322 | 98,708 | 54,454 | 40,318 |
| Income taxes - deferred | 20,621 | 15,615 | -7,945 | 10,872 | -126,613 |
| Accounts receivable | -7,748 | -7,159 | -2,079 | -10,434 | -5,516 |
| Accounts payable and accrued liabilities | 3,084 | 916 | 6,272 | -10,262 | -3,312 |
| Other Working Capital | -18,519 | -45,777 | -16,433 | -25,509 | -19,182 |
| Other Operating Activity | 209,504 | 69,777 | 50,842 | 64,616 | 45,814 |
| Operating Cash Flow | $189,389 | $154,649 | $145,274 | $125,717 | $77,032 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -6,758 | -13,000 | -17,187 | -1,160 |
| PPE Investments | -10,636 | -15,161 | -30,076 | -45,866 | -37,801 |
| Net Acquisitions | N/A | N/A | -32,000 | -424,042 | N/A |
| Purchase Of Investment | -252,212 | -137,608 | -387,685 | -602,431 | -546,516 |
| Sale Of Investment | 179,572 | 237,068 | 237,576 | 1,068,736 | 307,870 |
| Investing Cash Flow | $-83,276 | $77,541 | $-225,185 | $-20,790 | $-277,607 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 149,550 | N/A | 363,750 | 402,500 |
| Debt Repayment | 76,615 | -330,312 | -427,694 | N/A | -209,882 |
| Common Stock Issued | 2,298 | 4,750 | 27,341 | 26,655 | 47,764 |
| Common Stock Repurchased | -25,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -36,550 | -7,019 | -1,175 | -9,711 | -18,078 |
| Financing Cash Flow | $17,363 | $-183,031 | $-401,528 | $380,694 | $222,304 |
| Beginning Cash Position | 153,298 | 104,139 | 585,578 | 99,957 | 78,228 |
| End Cash Position | 276,774 | 153,298 | 104,139 | 585,578 | 99,957 |
| Net Cash Flow | $123,476 | $49,159 | $-481,439 | $485,621 | $21,729 |
| Free Cash Flow | |||||
| Operating Cash Flow | 189,389 | 154,649 | 145,274 | 125,717 | 77,032 |
| Capital Expenditure | -10,636 | -15,161 | -30,076 | -45,866 | -37,801 |
| Free Cash Flow | 178,753 | 139,488 | 115,198 | 79,851 | 39,231 |